Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MicroRNA profile in women with migraine treated with erenumab
2020-005310-17Phase 4Completed
- Sponsor
- ASL 1 Avezzano-Sulmona-L'Aquila
- Start
- Jun 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of erenumab in migraine, episodic migraine and chronic migraine, sponsored by ASL 1 Avezzano-Sulmona-L'Aquila. Started Jun 2021; status: completed.
02
Drugs
erenumab
03
Conditions
migraineepisodic migrainechronic migraine
Beyond the preview
Go deeper on 2020-005310-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005310-17.